Twin Cities entrepreneurs may soon have a new -- or at least improved -- resource for mentoring and seed funding, thanks to a federal grant to Cleveland economic development group JumpStart.
With publicly revealed investments of $250,000 from a Cleveland economic development group and $400,000 from an Illinois angel group, rudimentary mathematics tell us heart monitoring startup Endotronix Inc. has raised at least $650,000. But the company's latest funding round went above that amount, only Endotronix isn't saying by how much.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Endotronix Inc., which is developing a wireless heart sensor licensed from NASA, has received a $250,000 investment from economic development group JumpStart Ventures.
Dr. Raymond Onders will share a venture capital success story this week during his talk, "Helping Patients Breathe: From Superman to Synapse Biomedical -- How orphan diseases can lead to worldwide sales from Northeastern Ohio."
An Ohio board has approved a $546,055, seven-year tax credit for an expansion of CoverMyMeds LLC's Columbus office.
TheraVasc Inc., which is reformulating a drug to treat vascular diseases, has raised a $1.8 million Series A1 round of investment capital. But the company isn't stopping there -- it's looking to add about $450,000 to the round.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Nonprofit JumpStart Inc. has received a national economic development award for its work helping entrepreneurs develop their businesses.
Device maker MAX Endoscopy Inc. and drug developer TheraVasc Inc. each have received $250,000 follow-on investments from JumpStart Ventures, the investment arm of Northeast Ohio venture developer JumpStart Inc. The new commitments follow initial investments of the same amount that JumpStart made in the two companies last winter.
Updated 2:47 p.m., Aug. 5, 2010. Two-year-old drug development company ChanRx has received a $250,000 investment commitment from JumpStart Ventures, the investment arm of Northeast Ohio venture developer JumpStart Inc. ChanRx was spun off by ChanTest Corp. in Garfield Heights, Ohio, to develop small-molecule drugs — specifically, Vanoxerine — to treat atrial fibrillation, an increasingly […]
Healthcare technology and services company CoverMyMeds LLC has received a $250,000 investment commitment from JumpStart Ventures to develop its application for automated submission of requests to cover patient prescriptions that have been rejected by insurers. The Twinsburg, Ohio, company has developed Web- and phone-based tools that speed up and automate the submission of Prior Authorization […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
The Ohio Third Frontier Commission has awarded more than $3 million to entrepreneur-support organizations that provide services and investments to startup technology companies. The grant awards were made under the Third Frontier Pre-Seed Fund Initiative and Entrepreneurial Signature Program. — Cincinnati USA Regional Chamber was awarded $2 million for its Southwest Ohio Signature Program: The […]
Obstetricians, nurse-midwives and labor and delivery nurses now have a powerful — and inexpensive — tool for assessing a woman’s risk of delivering a baby too early. CerviLenz. The disposable device made by CerviLenz Inc. — a Chagrin Falls, Ohio, startup — was introduced today at the American Academy of Obstetricians and Gynecologists annual meeting […]
CardioInsight Technologies Inc. has raised $5.7 million in an ongoing funding round to help commercialize its heart-mapping technology. The Cleveland company's electrocardiographic mapping technology could help diagnose and treat electrical abnormalities of the heart, such as heart failure and arrhythmia.
Theravasc Inc., a Cleveland company that is reformulating an approved drug to treat vascular diseases, has received investment commitments of $500,000 to do its initial clinical study.
MAX Endoscopy Inc. in Macedonia, Ohio, has received a $250,000 investment commitment from JumpStart Inc., the venture development organization in Cleveland. MAX Endoscopy will use the money to formalize sales and marketing efforts for its fiber-optic technology that is used with endoscopes to treat hemorrhoids.